| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |